Cholestyramine Light and Metoprolol and Hydrochlorothiazide Extended-Release Tablets
Determining the interaction of Cholestyramine Light and Metoprolol and Hydrochlorothiazide Extended-Release Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using metoprolol and hydroCHLOROthiazide together may lower your blood pressure and slow your heart rate. This can cause dizziness, or feeling like you might pass out, weakness, fainting, fast or irregular heartbeats, or loss of blood glucose control. If you take both medications together, tell your doctor if you have any of these symptoms. You may need a dose adjustment or need your blood pressure checked more often to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Although they are often combined in clinical practice, diuretics and beta-blockers may increase the risk of hyperglycemia and hypertriglyceridemia in some patients, especially in patients with diabetes or latent diabetes. In addition, the risk of QT interval prolongation and arrhythmias (e.g. torsades de pointes) due to sotalol may be increased by potassium-depleting diuretics.
MANAGEMENT: Monitoring of serum potassium levels, blood pressure, and blood glucose is recommended during coadministration. Patients should be advised to seek medical assistance if they experience dizziness, weakness, fainting, fast or irregular heartbeats, or loss of blood glucose control.
- Dean S, Kendall MJ, Potter S, Thompson MH, Jackson DA "Nadolol in combination with indapamide and xipamide in resistant hypertensives." Eur J Clin Pharmacol 28 (1985): 29-33
- Dornhorst A, Powell SH, Pensky J "Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion." Lancet 1 (1985): 123-6
- "Product Information. Lozol (indapamide)." Rhone-Poulenc Rorer, Collegeville, PA.
- Marcy TR, Ripley TL "Aldosterone antagonists in the treatment of heart failure." Am J Health Syst Pharm 63 (2006): 49-58
- Roux A, Le Liboux A, Delhotal B, Gaillot J, Flouvat B "Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination." Eur J Clin Pharmacol 24 (1983): 801-6
Generic Name: cholestyramine
Brand name: Cholestyramine Light, Prevalite, Questran, Questran Light, Locholest, Locholest Light, Questran Light Packets, Prevalite Packets, Questran Packets
Synonyms: n.a.
Generic Name: hydrochlorothiazide / metoprolol
Brand name: Dutoprol, Lopressor HCT
Synonyms: Hydrochlorothiazide and metoprolol, Metoprolol and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cholestyramine Light-Metoprolol and Hydrochlorothiazide Tablets
- Cholestyramine Light-Metoprolol Extended-Release Capsules
- Cholestyramine Light-Metoprolol Extended-Release Tablets
- Cholestyramine Light-Metoprolol Injection
- Cholestyramine Light-Metoprolol Intravenous
- Cholestyramine Light-Metoprolol Succinate
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Cholestyramine Resin
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Choletec
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Cholic acid
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Choline magnesium trisalicylate
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Choline Magnesium Trisalicylate Liquid
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Cholografin Meglumine